Park Medi World Completes Acquisition of K P S Wellness

0 min read     Updated on 30 Jan 2026, 06:00 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Park Medi World has completed the acquisition of K P S Wellness, representing a strategic expansion move in the healthcare sector. This transaction allows the company to integrate K P S Wellness's operations into its existing business framework, potentially strengthening its market position and expanding service offerings in the wellness segment.

31321834

*this image is generated using AI for illustrative purposes only.

Park Medi World has successfully completed the acquisition of K P S Wellness, marking a significant corporate development for the healthcare company.

Acquisition Details

The company has announced that it has finalized the acquisition process of K P S Wellness. This transaction represents Park Medi World's strategic expansion efforts within the healthcare industry.

Strategic Implications

The completion of this acquisition allows Park Medi World to integrate K P S Wellness's operations and capabilities into its existing business framework. This move is expected to strengthen the company's market position and expand its service offerings in the wellness sector.

The successful completion of the acquisition demonstrates Park Medi World's commitment to growth through strategic partnerships and acquisitions. The integration of K P S Wellness is likely to enhance the company's operational capabilities and market reach in the healthcare and wellness segments.

like15
dislike

Park Medi World Reports 17.76% Revenue Growth in Q3 FY26, Hosts Maiden Earnings Call

4 min read     Updated on 28 Jan 2026, 06:16 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Park Medi World delivered robust Q3 FY26 performance with 17.76% revenue growth to ₹4,100 mn and 15.78% PAT growth to ₹528 mn. The company hosted its first earnings call, outlining expansion plans to add 660 beds in FY26 and reach 5,260 beds by FY28. Management expects to maintain EBITDA margins of 26%-27% while benefiting from recent CGHS rate hikes and becoming debt-free by February 2026.

31149992

*this image is generated using AI for illustrative purposes only.

Park Medi World Limited announced its revised earnings presentation for Q3 FY26 and nine-month period ended December 31, 2025, showcasing strong operational performance and continued execution of its growth strategy. The company delivered healthy revenue growth supported by stable patient volumes, improved case mix, and gradual ramp-up across newer and acquired hospitals. The company also hosted its maiden earnings call on January 29, 2026, marking the beginning of structured dialogue with the investor community.

Financial Performance Highlights

The company reported impressive financial results across key metrics for both quarterly and nine-month periods:

Metric Q3 FY26 Q3 FY25 YoY Growth 9M FY26 9M FY25 YoY Growth
Revenue (₹ mn) 4,100 3,481 17.76% 12,189 10,397 17.25%
EBITDA (₹ mn) 994 828 20.05% 3,170 2,826 12.17%
EBITDA Margin 24.25% 23.79% 0.46% 26.00% 27.18% -
PAT (₹ mn) 528 456 15.78% 1,968 1,380 42.60%
PAT Margin 12.89% 13.11% - 16.14% 13.27% -
EPS (₹) 1.35 1.19 - 5.09 3.59 -

Revenue from operations reached ₹4,100 mn in Q3 FY26, representing a 17.76% increase from ₹3,481 mn in the corresponding quarter of the previous year. For the nine-month period, revenue grew 17.25% to ₹12,189 mn from ₹10,397 mn in 9M FY25. The company also reported a 24% growth in patient footfall to 6.6 lakh patients in the nine-month period from 5.32 lakh patients in the previous year.

Strategic Acquisitions Drive Expansion

Park Medi World strengthened its platform through two significant strategic acquisitions during the period. The company acquired a 100% stake in KP Institute of Medical Sciences (KPIMS) in an all-cash transaction of ₹245 crore. KPIMS is a 360-bed, NABH-accredited multi super-speciality hospital and among the largest in the Agra region, strengthening Park Group's presence in Uttar Pradesh under its cluster-based expansion strategy.

Additionally, the company acquired Febris Multi-Speciality Hospital in New Delhi through its wholly owned subsidiary Blue Heavens Health Care Pvt. Ltd. under the IBC process. This 200-bed multi-speciality hospital is strategically located in a densely populated catchment with access to Delhi, Haryana, and Western UP.

Operational Excellence and Capacity Expansion

The company demonstrated strong operational metrics with improved capacity utilization:

Parameter 9M FY26 9M FY25 Q3 FY26
Bed Capacity 3,250 3,000 3,250
Occupancy Ratio 65% 62% 63%
ARPOB (₹) 27,406 25,527 27,482
ALOS (days) 6.34 6.59 6.31

The company's bed capacity increased to 3,250 beds in 9M FY26 from 3,000 beds in the corresponding previous period. The occupancy ratio improved to 65% in 9M FY26 compared to 62% in 9M FY25, while Average Revenue per Operating Bed (ARPOB) rose to ₹27,406 from ₹25,527.

Aggressive Expansion Plans and Technology Adoption

During the earnings call, management outlined ambitious expansion plans to add 660 beds within FY26 itself. The Agra facility (360 beds) is scheduled to commence operations by February 15, 2026, while the Panchkula Greenfield project (300 beds) will start in the first week of March 2026. By FY28, the company plans to reach approximately 5,260 beds from the current 3,250 beds.

Expansion Timeline Facility Beds Expected Start
FY26 Agra (KPIMS) 360 February 2026
FY26 Panchkula 300 March 2026
FY27 Kanpur & Delhi 500 -
FY28 Gorakhpur, Ambala, Rohtak 850 -

The company has invested heavily in advanced medical technology, including three fifth-generation da Vinci robots for robotic-assisted surgeries. Management reported conducting 25-30 kidney transplants per month and over 300 robotic joint replacements, contributing to improved product mix and higher ARPOB.

Financial Strength and Debt Reduction

Park Medi World significantly strengthened its balance sheet post-IPO. The company reduced its total term debt from ₹425 crore pre-IPO to approximately ₹15 crore as of January 31, 2026, with plans to become completely debt-free by February 2026. This positions the company well for funding its aggressive expansion plans.

Management Outlook and Strategic Focus

According to management commentary during the earnings call, the company remains focused on disciplined capital allocation, balance sheet strength, and measured expansion post-IPO. The company expects to maintain EBITDA margins in the 26%-27% range and PAT margins of 15%-17% over the medium to long term. Management also highlighted the recent CGHS rate hike of 12%-15%, which is expected to benefit the company from FY27, though they are conservatively accounting for a 7.5% impact.

Park Medi World maintains its position as the largest private hospital chain in Haryana with an extensive presence across North India, including Haryana, Delhi, Punjab, and Rajasthan. The company's cluster-based expansion approach enables brand recognition and resource sharing among hospitals located in proximity, supporting operational efficiencies and improved utilization over time.

like17
dislike

More News on Park Medi World